The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery

NCT01606111 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped Poor patient recruitment

Conditions

Traumatic Brain Injury

Interventions

DRUG: Cerebrolysin
DRUG: 0.9% NaCl, saline

Sponsor

Ever Neuro Pharma GmbH